Pei Zhang

Dr. Pei Zhang

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2021 in Environmental Science & Technology Letters
Verified
Journal Article
Open access
PZPei Zhang
Pei Zhang
CCChristopher Carlsten
Christopher Carlsten
RCRomanas Chaleckis
Romanas Chaleckis
KHKati Hanhineva
Kati Hanhineva
MHMengna Huang
Mengna Huang
Craig WheelockCraig Wheelock
Craig Wheelock
The concept of the exposome was introduced over 15 years ago to reflect the important role that the environment exerts on health and disease. While originally viewed as a call-to-arms to develop more comprehensive exposure assessment methods applicable at the individual level and throughout the life course, the scope of the exposome has now expanded to include the associated biological response. In order to explore these concepts, a workshop was hosted by the Gunma University Initiative for Advanced Research (GIAR, Japan) to discuss the scope of exposomics from an international and multidisciplinary perspective. This Global Perspective is a summary of the discussions with emphasis on (1) top-down, bottom-up, and functional approaches to exposomics, (2) the need for integration and standardization of LC- and GC-based high-resolution mass spectrometry methods for untargeted exposome analyses, (3) the design of an exposomics study, (4) the requirement for open science workflows including mass spectral libraries and public databases, (5) the necessity for large investments in mass spectrometry infrastructure in order to sequence the exposome, and (6) the role of the exposome in precision medicine and nutrition to create personalized environmental exposure profiles. Recommendations are made on key issues to encourage continued advancement and cooperation in exposomics.

10 July 2020 in Analytical Chemistry
Verified
Journal Article
Closed access
ITIpputa Tada
Ipputa Tada
RCRomanas Chaleckis
Romanas Chaleckis
HTHiroshi Tsugawa
Hiroshi Tsugawa
IMIsabel Meister
Isabel Meister
PZPei Zhang
Pei Zhang
MAMasanori Arita
Masanori Arita

26 October 2019 in Metabolites
Verified
Journal Article
Open access
PDF file
ITIpputa Tada
Ipputa Tada
HTHiroshi Tsugawa
Hiroshi Tsugawa
IMIsabel Meister
Isabel Meister
PZPei Zhang
Pei Zhang
RSRie Shu
Rie Shu
RCRomanas Chaleckis
Romanas Chaleckis
Accurate metabolite identification remains one of the primary challenges in a metabolomics study. A reliable chemical spectral library increases the confidence in annotation, and the availability of raw and annotated data in public databases facilitates the transfer of Liquid chromatography coupled to mass spectrometry (LC–MS) methods across laboratories. Here, we illustrate how the combination of MS2 spectra, accurate mass, and retention time can improve the confidence of annotation and provide techniques to create a reliable library for all ion fragmentation (AIF) data with a focus on the characterization of the retention time. The resulting spectral library incorporates information on adducts and in-source fragmentation in AIF data, while noise peaks are effectively minimized through multiple deconvolution processes. We also report the development of the Mass Spectral LIbrary MAnager (MS-LIMA) tool to accelerate library sharing and transfer across laboratories. This library construction strategy improves the confidence in annotation for AIF data in LC–MS-based metabolomics and will facilitate the sharing of retention time and mass spectral data in the metabolomics community.

8 October 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
JZJiahui Zheng
Jiahui Zheng
HLHuan Li
Huan Li
PZPei Zhang
Pei Zhang
SYShijun Yue
Shijun Yue
BZBingtao Zhai
Bingtao Zhai
JWJing Wang
Jing Wang
Ulcerative colitis (UC) is a chronic recurrent inflammatory disease of the gastrointestinal tract. Recent studies demonstrate that the phenolic tannin paeonol (Pae) attenuates UC in mouse models by downregulating inflammatory factors. However, its molecular mechanism for UC treatment has not been explored from the perspective of the gut microbiota and metabolomics. In this study, we investigated the effects of Pae on colonic inflammation, intestinal microbiota and fecal metabolites in 3% dextran sodium sulfate (DSS) induced BALB/c UC mice. Pae significantly improved the clinical index, relieved colonic damage, reduced cytokine levels, and restored the integrity of the intestinal epithelial barrier in UC mice. In addition, Pae increased the abundance of gut microbiota, partially reversed the disturbance of intestinal biota composition, including Lactobacillus and Bacteroides, and regulated metabolite levels, such as bile acid (BA) and short-chain fatty acid (SCFA). In conclusion, our study provides new insight on Pae remission of UC.

23 May 2019 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
WHWanqiu Huang
Wanqiu Huang
YXYazhou Xu
Yazhou Xu
YZYuxin Zhang
Yuxin Zhang
PZPei Zhang
Pei Zhang
QZQianqian Zhang
Qianqian Zhang
Fengguo XuFengguo Xu
Fengguo Xu

22 January 2025 in Advanced Science
Verified
Journal Article
Open access
RSRuiqi Sun
Ruiqi Sun
YZYuanyuan Zhang
Yuanyuan Zhang
XZXian Zhao
Xian Zhao
TTTian Tang
Tian Tang
YCYuepeng Cao
Yuepeng Cao
Fengguo XuFengguo Xu
Fengguo Xu
Patients with ulcerative colitis (UC) have a higher risk of developing colorectal cancer (CRC), however, the metabolic shifts during the UC‐to‐CRC transition remain elusive. In this study, an AOM‐DSS‐induced three‐stage colitis‐associated colorectal cancer (CAC) model is constructed and targeted metabolomics analysis and pathway enrichment are performed, uncovering the metabolic changes in this transition. Spatial metabolic trajectories in the “normal‐to‐normal adjacent tissue (NAT)‐to‐tumor” transition, and temporal metabolic trajectories in the “colitis‐to‐dysplasia‐to‐carcinoma” transition are identified through K‐means clustering of 74 spatially and 77 temporally differential metabolites, respectively. The findings reveal two distinct metabolic profile categories during the inflammation‐to‐cancer progression: those with consistent changes, either increasing (e.g., kynurenic acid, xanthurenic acid) or decreasing (e.g., long‐chain fatty acids, LCFAs), and those enriched at specific disease stages (e.g., serotonin). Further analysis of metabolites with consistent temporal trends identifies eicosapentaenoic acid (EPA) as a key metabolite, potentially exerting anti‐inflammatory and anti‐cancer effects by inhibiting insulin‐like growth factor binding protein 5 (IGFBP5). This study reveals novel metabolic mechanisms underlying the transition from UC to CAC and suggests potential targets to delay the progression.